PROAZITAX 60MG SOL INJ IV CT FA VD TRANS X 1,5ML + DIL FA VD TRANS X 4,5ML

Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil

  • Número de registro 1004311980013
  • GGREM 508017010115604
  • Código de barras 7891317190637

O que a fonte publica

Detentor do registro
EUROFARMA LABORATORIOS S.A.
Princípios ativos
CABAZITAXEL
Embalagem
60MG SOL INJ IV CT FA VD TRANS X 1,5ML + DIL FA VD TRANS X 4,5ML
Tipo de produto
Similar
Classe terapêutica
L1C2 - AGENTES ANTINEOPLÁSICOS TAXANOS

Nomes pelos quais este registro é encontrado

Dados completos da fonte
br:cmed:presentations:508017010115604
{
  "name": "PROAZITAX 60MG SOL INJ IV CT FA VD TRANS X 1,5ML + DIL FA VD TRANS X 4,5ML",
  "holder": "EUROFARMA LABORATORIOS S.A.",
  "stripe": null,
  "barcodes": [
    "7891317190637"
  ],
  "confaz87": false,
  "currency": "BRL",
  "marketed": null,
  "ggremCode": "508017010115604",
  "useDomain": "unknown",
  "capApplies": null,
  "icmsExempt": false,
  "holderTaxId": "61.190.096/0001-92",
  "priceRegime": "Regulado",
  "productName": "PROAZITAX",
  "productType": "Similar",
  "hospitalOnly": true,
  "presentation": "60MG SOL INJ IV CT FA VD TRANS X 1,5ML + DIL FA VD TRANS X 4,5ML",
  "sourceStatus": null,
  "supplyRegime": null,
  "factoryPrices": {
    "icms-0": "22458.58",
    "icms-12": "25521.12",
    "icms-17": "27058.52",
    "icms-18": "27388.51",
    "icms-19": "27726.64",
    "icms-20": "28073.23",
    "icms-21": "28428.59",
    "icms-22": "28793.04",
    "icms-23": "29166.98",
    "icms-17.5": "27222.52",
    "icms-19.5": "27898.86",
    "icms-20.5": "28249.79",
    "icms-22.5": "28978.82",
    "icms-12-alc": "25214.85",
    "icms-17-alc": "26733.82",
    "icms-18-alc": "27059.85",
    "icms-19-alc": "27393.92",
    "icms-20-alc": "27736.32",
    "icms-21-alc": "28087.44",
    "icms-22-alc": "28447.52",
    "icms-23-alc": "28816.96",
    "withoutTaxes": "22189.08",
    "icms-17.5-alc": "26895.83",
    "icms-19.5-alc": "27564.07",
    "icms-20.5-alc": "27910.78",
    "icms-22.5-alc": "28631.07"
  },
  "pisCofinsList": "Positiva",
  "substanceText": "CABAZITAXEL",
  "targetSpecies": [],
  "consumerPrices": null,
  "invalidBarcodes": [],
  "activeSubstances": [
    "CABAZITAXEL"
  ],
  "therapeuticClass": "L1C2 - AGENTES ANTINEOPLÁSICOS TAXANOS",
  "commercialisation": {
    "year": 2025,
    "marketed": true
  },
  "priceAnalysisNote": null,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "br.anvisa.cmed-prices"
  },
  "patientEligibility": "not-assessed",
  "registrationNumber": "1004311980013",
  "targetSpeciesStatus": "not-reported",
  "administrativeStatus": "unknown",
  "prescriptionCategory": "unknown",
  "prescriptionRequired": null,
  "therapeuticClassCode": "L1C2",
  "commercialDestination": null,
  "registrationNumberFlag": null
}

Leia este registro a partir do seu próprio software

O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=br" \
  --data-urlencode "sourceId=br.anvisa.cmed-prices" \
  --data-urlencode "id=br:cmed:presentations:508017010115604"